Competition

  • March 06, 2026

    Senate Dems Float Bill To Break Up 'Meatpacking Monopoly'

    Senate Democrats have introduced a bill to break up the country's largest meatpacking conglomerates over concerns that concentration in the beef, pork and chicken sectors has contributed to higher food prices and worse deals for farmers.

  • March 06, 2026

    Constantine Cannon Defends Handling Of Sutter $75M Fee

    Constantine Cannon LLP pushed back against Schneider Wallace Cottrell Kim LLP's allegations it unfairly reduced Schneider Wallace's share of a $75.4 million fee award in Sutter Health's $228.5 million antitrust deal, arguing in California federal court that the firm "sat on the sidelines" for most of the decadelong fight and isn't entitled to a bigger cut.

  • March 06, 2026

    Express Scripts Ducks RICO Suit Over Acthar Price Hike

    Express Scripts Inc. and its affiliates may have worked with drugmaker Mallinckrodt to hike the price of seizure medication Acthar from $40 to $40,000, but a proposed class action by third-party payors failed to allege the high prices were a result of fraud, a Pennsylvania federal judge ruled.

  • March 06, 2026

    'Which' Fights To Keep Free ICloud Users In £3B Apple Claim

    Which has urged the Competition Appeal Tribunal not to strike out iCloud users who never paid for the services from its proposed £3 billion ($4 billion) collective action claim against Apple, arguing that they have suffered a loss.

  • March 06, 2026

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen British American Tobacco sued by more than 100 investors, the government bring a claim against a COVID-19 supplier of personal protective equipment, Annington Funding sue its new corporate trustees on the Financial List, and Piers Morgan hit with a defamation claim from a pro-Israel barrister he interviewed on his YouTube channel. 

  • March 05, 2026

    'Addiction' Became A 'Dirty Word' At Instagram, Jury Hears

    A former executive and consultant for Meta testified Thursday in bellwether litigation over claims that its subsidiary Instagram is harmful to children, telling a Los Angeles jury that between his two stints with the company, he saw "addiction" go from an openly researched topic to a taboo "dirty word."

  • March 05, 2026

    Berkshire Unit Wants Out Of Broker Commission Fees Suit

    A Berkshire Hathaway unit that owns real estate brokerage HomeServices of America Inc. urged a Missouri federal court to grant its quick win bid against an antitrust class action that accused the National Association of Realtors and brokerages of running an anticompetitive scheme that inflates buyer-broker commission fees.

  • March 05, 2026

    NCAA Takes Eligibility Battle With QB To Miss. Supreme Court

    The NCAA on Thursday asked the Mississippi Supreme Court to overturn a lower court injunction allowing star quarterback Trinidad Chambliss to exceed its eligibility limits and play football next season for the University of Mississippi.

  • March 05, 2026

    Signal 'Never' Regular Biz Practice, Amazon Tells FTC Judge

    Amazon.com Inc. assailed the Federal Trade Commission for accusing the company of using auto-deleting Signal chats and improper privilege claims to hide evidence of rules that created an artificial pricing floor across online retail stores, telling a Washington federal judge that it never hid anything.

  • March 05, 2026

    9th Circ. Denies Bail Pending Nurse Wage-Fixing Appeal

    A Ninth Circuit panel summarily refused to allow a Las Vegas home nursing executive to avoid prison while appealing the U.S. Department of Justice's first-ever criminal wage-fixing conviction.

  • March 05, 2026

    Nielsen Urges 2nd Circ. To Nix Data-Tying Order

    Ratings provider Nielsen has told the Second Circuit that a lower court injunction blocking it from conditioning access to its nationwide radio ratings data on the purchase of local market data intruded on its private price negotiations with radio giant Cumulus Media.

  • March 05, 2026

    Fed. Circ. Mulls Patents In Penile Implant Trade Secret Win

    A Federal Circuit panel on Thursday grilled both sides in a trade secret dispute over penile implants that resulted in an $18.3 million judgment against defendants, repeatedly questioning attorneys about whether existing patents doomed the trade secrets claimed by International Medical Devices and its founder, Dr. James Elist.

  • March 05, 2026

    Meta Agrees To Let Rival AI Bots On WhatsApp In Europe

    Meta Platforms will let rival artificial intelligence providers back on its WhatsApp service in Europe for a fee for the next year, after enforcers threatened to impose restrictive measures as part of an antitrust investigation, the company confirmed Thursday.

  • March 05, 2026

    EU Approves KKR, PAG's $3B Sapporo Property Biz Buy

    The European Commission has approved global investment firm KKR & Co. Inc. and private asset manager PAG's $3 billion acquisition of Sapporo Holdings Ltd.'s real estate business.

  • March 05, 2026

    College Athletes Balk At Exclusion From White House Panel

    The White House's apparent failure to invite any active student-athletes to this week's college sports policy roundtable drew fire on Thursday from a college athletes' advocacy group, which reiterated its demand for a broad collective bargaining agreement covering amateur athletics.

  • March 05, 2026

    Enviri, Veolia's $3B Clean Earth Deal Gets US Antitrust Nod

    Enviri Corp. has disclosed the early termination of the waiting period under the Hart-Scott-Rodino Act for its planned sale of Clean Earth to Veolia Environnement SA for more than $3 billion.

  • March 05, 2026

    Water Cos. Beat Attempt To Revive £800M Sewage Claim

    An environmental consultant cannot revive an £800 million ($1.1 billion) collective action against water utility companies for their allegedly underreported sewage discharge after a divided Court of Appeal held Thursday that misleading of the industry regulator was an "essential ingredient" of the claim.

  • March 04, 2026

    CVS Beats Antitrust Suit Over 340B Drug Program, For Good

    CVS Health Corp. permanently defeated a proposed antitrust class action alleging it forced hospitals in a discount drug program to use its third-party administrator for savings, when a Pennsylvania federal judge ruled Tuesday that hospitals aren't required to contract with CVS and can pick Walgreens or other participating pharmacies to contract with.

  • March 04, 2026

    Senator Asks DOJ To Reassess NFL's Antitrust Exemption

    It cost nearly $1,000 all said to watch every single National Football League game this season, between cable packages and streaming services, and one senator is wondering whether it's time for the U.S. Department of Justice to take another look at the league's antitrust immunity.

  • March 04, 2026

    Volkswagen Sued Over Direct-To-Consumer Scout EV Offers

    Volkswagen offering to sell new electric Scout vehicles directly to customers is a "blatant" breach of its legal and contractual obligations to dealerships, two dealerships alleged in a putative class action filed in Virginia federal court that claims Volkswagen has already made at least $15 million from online reservation deposits on Scout's website.

  • March 04, 2026

    Colo. Judge Dismisses Builder's Housing Fees Suit

    A Colorado federal judge has dismissed a Denver home builder's complaint against the city contending fees and restrictions required through two ordinances violate the takings clause of the Fifth Amendment.

  • March 04, 2026

    Judge Calls FTC's Boycott Subpoenas 'Exceedingly Broad'

    The Federal Trade Commission battled Wednesday with the latest challenger to its administrative subpoenas examining an alleged advertising boycott of conservative voices in front of a D.C. federal judge who offered few hints about whether she'll temporarily block the information demands but did call them extremely broad.

  • March 04, 2026

    Google Agrees To More Android Changes In Deal With Epic

    Google and Epic Games offered a California federal court a new proposal Wednesday to modify an injunction issued in a monopolization case over the distribution apps on Android devices, while also reaching a broader agreement on global changes to the mobile operating system.

  • March 04, 2026

    Tyson Escapes Feed Ingredient Co.'s Antitrust Claims

    Tyson Foods defeated an antitrust case in Georgia federal court accusing it of driving American Proteins Inc. out of the poultry rendering market in the Southeast, after the court found a lack of harm to American Proteins and no evidence of a conspiracy.

  • March 04, 2026

    Sandoz Parent Targets Walmart, Southwest Generic Drug Suits

    Sandoz parent company Sandoz AG contested generic drug price-fixing complaints from Southwest Airlines, Walmart, Walgreen and United Healthcare, arguing that the direct action plaintiffs cannot pursue the company in the wider Pennsylvania federal court multidistrict litigation because the Swiss firm is too far removed from its Sandoz Inc. subsidiary.

Expert Analysis

  • Takeaways From 1st DOJ Antitrust Whistleblower Payout

    Author Photo

    The U.S. Justice Department's recent $1 million antitrust whistleblower reward accelerates the race to report by signaling that the Antitrust Division's program can result in substantial financial awards and reinforcing the need for corporate compliance programs that reach beyond core components, say attorneys at Pillsbury.

  • Series

    Trail Running Makes Me A Better Lawyer

    Author Photo

    Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.

  • Navigating New Risks Amid Altered Foreign Issuer Landscape

    Author Photo

    The U.S. Securities and Exchange Commission's potential rulemaking to redefine who qualifies as a foreign private issuer will shape securities regulation and enforcement for decades, affecting not only FPIs and U.S. investors but also the U.S.' position in global capital markets, says Elisha Kobre at Sheppard.

  • Reflections From High Court Oral Args Over Fed Gov. Removal

    Author Photo

    In the oral arguments last month for Trump v. Cook, which asks the U.S. Supreme Court to clarify the circumstances under which the president can remove a Federal Reserve Board governor, the justices appeared skeptical about ruling on the substantive issues in view of the limited record and analysis, say attorneys at Ballard Spahr.

  • CFIUS Risk Lessons From Chips Biz Divestment Order

    Author Photo

    President Donald Trump's January executive order directing HieFo to unwind its 2024 acquisition of a semiconductor business with ties to China underscores that even modestly sized transactions can attract CFIUS interest if they could affect strategic areas prioritized by the U.S. government, say attorneys at Debevoise.

  • Malpractice Claim Assignability Continues To Divide Courts

    Author Photo

    Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.

  • Tips For Financial Advisers Facing TRO From Former Firm

    Author Photo

    The Eighth Circuit's recent decision in Choreo v. Lors, overturning a lower court's sweeping injunction after financial advisers moved to a new firm, gives advisers new strategies to fight restraining orders from their old firms, such as focusing on whether the alleged irreparable harm is calculable, say attorneys at Kutak Rock.

  • How Latest Nasdaq Proposals Stand To Raise Listings Quality

    Author Photo

    Nasdaq's recent proposals stand to heighten both quantitative and qualitative standards for issuers, which, if approved, may bring investors stronger market integrity and access but also raise the listings bar, say attorneys at Norton Rose.

  • Opinion

    CFIUS Must Adapt To Current Foreign Investment Realities

    Author Photo

    To continue protecting the U.S.’ long-term strategic and economic interests, the Committee on Foreign Investment in the United States should implement practical enhancements that leverage technology, expertise and clear communication, and enable it to keep pace with evolving demands, says attorney Sohan Dasgupta.

  • Bipartisan Enforcement Is Rising In Consumer Finance

    Author Photo

    Activity over the past year suggests a bipartisan state enforcement wave is rippling across the consumer finance industry, which follows a blueprint set out by former Consumer Financial Protection Bureau Director Rohit Chopra, who notably now leads a Democratic Attorneys General Association working group, say attorneys at Hudson Cook.

  • Series

    Teaching Logic Makes Me A Better Lawyer

    Author Photo

    Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.

  • Series

    Law School's Missed Lessons: Practicing Resilience

    Author Photo

    Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

  • Upshot Of 'Skinny Label' Case May Go Beyond Pharma

    Author Photo

    The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.

  • 4 Lessons From FTC's Successful Bid To Block Edwards Deal

    Author Photo

    The Federal Trade Commission's recent victory in blocking Edwards Lifesciences' acquisition of JenaValve offers key insights for deals in life sciences and beyond, including considerations around nonprice dimensions and clear skies provisions, say attorneys at Orrick.

  • Assessing Factors Behind Biosimilar Uptake And Competition

    Author Photo

    As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.